NCT01511640View on ClinicalTrials.gov

Behavioral Effects of Pregabalin and Cannabis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Cannabis-use Disorders
Interventions
DRUG

Pregabalin

pregabalin 2x daily for duration of study

DRUG

Placebo

placebo 2x daily for duration of study

Trial Locations (1)

40536-0086

Laboratory of Human Behavioral Pharmacology, Lexington

All Listed Sponsors
lead

Joshua A. Lile, Ph.D.

OTHER

NCT01511640 - Behavioral Effects of Pregabalin and Cannabis | Biotech Hunter | Biotech Hunter